Replies to post #5460 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Jp2011, welcome to the board. There are three patent applications in play.

The big one:
Methods for decreasing cardiovascular risk in postmenopausal women

and

Methods for treating sexual dysfunction while decreasing cardiovascular risk


COMMERCIAL SCALE PRODUCTION METHODS FOR TRANSDERMAL HORMONE FORMULATIONS

If there is a connection between the AVARX removal of Libigel, it would be linked to all three.

JMHO